- Home
- EPAM vs CORT Comparison
EPAM vs CORT Comparison
Compare EPAM & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAM
- CORT
- Stock Information
- Founded
- EPAM 1993
- CORT 1998
- Country
- EPAM United States
- CORT United States
- Employees
- EPAM N/A
- CORT N/A
- Industry
- EPAM EDP Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- EPAM Technology
- CORT Health Care
- Exchange
- EPAM Nasdaq
- CORT Nasdaq
- Market Cap
- EPAM 8.2B
- CORT 7.1B
- IPO Year
- EPAM 2012
- CORT N/A
- Fundamental
- Price
- EPAM $183.76
- CORT $75.08
- Analyst Decision
- EPAM Buy
- CORT Strong Buy
- Analyst Count
- EPAM 16
- CORT 4
- Target Price
- EPAM $229.00
- CORT $142.00
- AVG Volume (30 Days)
- EPAM 750.8K
- CORT 1.3M
- Earning Date
- EPAM 05-08-2025
- CORT 05-05-2025
- Dividend Yield
- EPAM N/A
- CORT N/A
- EPS Growth
- EPAM N/A
- CORT 8.36
- EPS
- EPAM 7.15
- CORT 1.14
- Revenue
- EPAM $4,864,167,000.00
- CORT $685,446,000.00
- Revenue This Year
- EPAM $14.70
- CORT $35.85
- Revenue Next Year
- EPAM $7.82
- CORT $35.22
- P/E Ratio
- EPAM $25.70
- CORT $65.80
- Revenue Growth
- EPAM 4.72
- CORT 30.93
- 52 Week Low
- EPAM $138.15
- CORT $25.35
- 52 Week High
- EPAM $269.00
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- EPAM 65.02
- CORT 57.68
- Support Level
- EPAM $156.21
- CORT $68.86
- Resistance Level
- EPAM $189.62
- CORT $73.36
- Average True Range (ATR)
- EPAM 4.67
- CORT 3.26
- MACD
- EPAM 3.63
- CORT 0.12
- Stochastic Oscillator
- EPAM 83.80
- CORT 95.28
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.